I obtained my PhD (Immunology of gestation) in Bordeaux, France. After a post-doctoral period in Edinburgh (Scotland, UK), where I worked on the role of the protease/antiprotease balance in lung mucosal inflammation, I moved to Pr J. Gauldie's lab (McMaster University, Hamilton, Canada) where I used gene transfer techniques to promote lung protection in inflammatory murine models (1992-1996). I then joined the MRC Center for Inflammation (Edinburgh, Scotland) as a PI (1996-2006) where my team worked on the role of antimicrobial molecules in Pseudomonas aeruginosa lung infection models. In 2006, I joined the Pasteur Institute (Paris, France, 2006-2014), as a PI and Professor of Immunology, working on TLR5-Pseudomonas and Influenza-proteases signalling pathways and the deleterious role of neutrophil host proteases in cystic fibrosis. In 2014, I moved to the INSERM U 1152 (HÃ´pital Bichat, Paris, France), where our team is working on deciphering the protective role of host endogenous antimicrobials and nanoparticles in lung inflammation in cystic fibrosis and other lung pathologies I have recently served on the advisory board for the : 10th World congress on Inflammation (Paris, 25-29/06/2011) and have participated in the organization of the Â« Lung Science Conferences Â» (European Respiratory Society) from 2013 to 2016 as co-â€˜Program coordinatorâ€™. I am currently a member of the organizing committe of the Lung Science Conference program (Estoril, Portugal), and a â€˜Program advisorâ€™ , responsible for over-seeing the scientific program at the annual ERS (European Research Society) congress.